Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Neoplasms 1Hematologic Neoplasms 1Depression 1Death 1Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 629pembrolizumab 559Magnetic Resonance Spectroscopy 539Carboplatin 423Cyclophosphamide 371Cisplatin 371Biopsy 357Paclitaxel 304Nivolumab 301Gemcitabine 299Radiotherapy 270Bevacizumab 238Dexamethasone 207fludarabine 205Docetaxel 189durvalumab 178atezolizumab 176Oxaliplatin 172Fluorouracil 167venetoclax 164Rituximab 164Pemetrexed 162Radiation 159Doxorubicin 159Capecitabine 158Radiosurgery 147Etoposide 137Ipilimumab 134Leucovorin 133Lenalidomide 130

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Focus Groups × 90 days × Clear all
NCT07520188 2026-06-05

CASCADE3002

UNC Lineberger Comprehensive Cancer Center

Not yet recruiting
3,500 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06786104 2026-05-14

VIDEO-PEDS

Massachusetts General Hospital

Phase NA Recruiting
567 enrolled

Death, Neoplasms

NCT05012124 2026-04-16

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

University of Washington

Phase NA Terminated
297 enrolled
Other hematologic neoplasm

Depression, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡